Tgf β receptor 1: An immune susceptibility gene in hpv-associated cancer

Cancer Research

Volumn 74, Issue 23, 2014, Pages 6833-6844

  Levovitz, Chaya ^a   Chen, Dan ^b   Ivansson, Emma ^b   Gyllensten, Ulf ^b   Finnigan, John P ^a   Alshawish, Sara ^f   Zhang, Weijia ^a   Schadt, Eric E ^a,c   Posner, Marshal R ^a,d   Genden, Eric M ^a,d,e   Boffetta, Paolo ^a,e   Sikora, Andrew G ^a,d,e  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SCIENCE FOR LIFE LABORATORY   (Sweden)

^c Mount Sinai Institute for Genomics and Multiscale Biology   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Tisch Cancer Institute   (United States)

^f Department of Oncological Sciences Icahn School of Medicine at Mount Sinai ^*

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SERINE THREONINE KINASE; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CANCER GROWTH; CANCER PATIENT; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEAD AND NECK CANCER; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; MAJOR CLINICAL STUDY; NONHUMAN; OROPHARYNX CANCER; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; WART VIRUS; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; NEOPLASM; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PROCEDURES; VIROLOGY;

FEMALE; GENOME-WIDE ASSOCIATION STUDY; HOST-PATHOGEN INTERACTIONS; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84917706840     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-0602-T     Document Type: Article

References (72)

1. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124:1626-36.
2. Ihloff AS, Petersen C, Hoffmann M, Knecht R, Tribius S. Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncol 2010;46:705-11.
3. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and metaanalysis of trends by time and region. Head Neck 2013;35:747-55.
4. Hocking JS, Stein A, Conway EL, Regan D, Grulich A, Law M, et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 2011;104:886-91.
5. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-301.
6. Lindau ST, Drum ML, Gaumer E, Surawska H, Jordan JA. Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol 2008;112:979-89.
7. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 2011;204:566-73.
8. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
9. Magnusson PK, Lichtenstein P, Gyllensten UB. Heritability of cervical tumours. Int J Cancer 2000;88:698-701.
10. Fuentes-Gonzalez AM, Contreras-Paredes A, Manzo-Merino J, Lizano M. The modulation of apoptosis by oncogenic viruses. Virol J 2013;10:182.
11. Kreitchmann R, Bajotto H, daSilva DA, Fuchs SC. Squamous intraepithelial lesions in HIV-infected women: prevalence, incidence, progression and regression. Arch Gynecol Obstet 2013;288: 1107-13.
12. Tami-Maury IM, Willig JH, Jolly PE, Vermund S, Aban I, Hill JD, et al. Prevalence, incidence, and recurrence of oral lesions among HIVinfected patients on HAART in Alabama: a two-year longitudinal study. South Med J 2011;104:561-6.
13. McKay JD, Truong T, Gaborieau V, Chabrier A, Chuang SC, Byrnes G, et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet 2011;7:e1001333.
14. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009;10:318-29.
15. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008;118:1590-605.
16. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
17. Korte A, Farlow A. The advantages and limitations of trait analysis with GWAS: a review. Plant Methods 2013;9:29.
18. Sun YV. Integration of biological networks and pathways with genetic association studies. Hum Genet 2012;131:1677-86.
19. Farber CR. Systems-level analysis of genome-wide association data. G3 2013;3:119-29.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007;81:559-75.
21. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-9.
22. Chen D, McKay JD, Clifford G, Gaborieau V, Chabrier A, Waterboer T, et al. Genome-wide association study of HPV seropositivity. Hum Mol Genet 2011;20:4714-23.
23. Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, Purcell SM, Sklar P, et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet 2009;5:e1000534.
24. Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y, et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 2011;7:e1001273.
25. Diaz-Sanchez V, Larrea F, Ulloa-Aguirre A, Garza-Flores J, Richards E, Veayra F. Absorption of dihydrotestosterone (DHT) after its intramuscular administration. Fertil Steril 1989;51:493-7.
26. Ivansson EL, Juko-Pecirep I, Erlich HA, Gyllensten UB. Pathwaybased analysis of genetic susceptibility to cervical cancer in situ: HLA-DPB1 affects risk in Swedish women. Genes Immun 2011;12: 605-14.
27. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated datamining platform. Neoplasia 2004;6:1-6.
28. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333:1157-60.
29. Available from: http://cancergenome.nih.gov.
30. Smith EM, Pawlita M, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer 2010;127:111-7.
31. Smith EM, Ritchie JM, Pawlita M, Rubenstein LM, Haugen TH, Turek LP, et al. Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer 2007;120:825-32.
32. Halec G, Holzinger D, Schmitt M, Flechtenmacher C, Dyckhoff G, Lloveras B, et al. Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer 2013;109:172-83.
33. Iancu IV, Botezatu A, Goia-Rusanu CD, Stanescu A, Huica I, Nistor E, et al. TGF-beta signalling pathway factors in HPV-induced cervical lesions. Roum Arch Microbiol Immunol 2010;69:113-8.
34. Deng W, Tsao SW, Kwok YK, Wong E, Huang XR, Liu S, et al. Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells. Cancer Res 2008;68:7200-9.
35. French D, Belleudi F, Mauro MV, Mazzetta F, Raffa S, Fabiano V, et al. Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway. Mol Cancer 2013;12:38.
36. Guan X, Sturgis EM, Lei D, Liu Z, Dahlstrom KR, Wei Q, et al. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res 2010;16:1416-22.
37. Garay E, Patino-Lopez G, Islas S, Alarcon L, Canche-Pool E, Valle-Rios R, et al. CRTAM: A molecule involved in epithelial cell adhesion. J Cell Biochem 2010;111:111-22.
38. ManickamA, SivanandhamM. Mycobacterium bovisBCGand purified protein derivative-induced reduction in the CD80 expression and the antigen up-take function of dendritic cells from patients with cervical cancer. Eur J Obstet Gynecol Reprod Biol 2011;159:413-7.
39. Bhairavabhotla RK, Verm V, Tongaonkar H, Shastri S, Dinshaw K, Chiplunkar S. Role of IL-10 in immune suppression in cervical cancer. Indian J Biochem Biophys 2007;44:350-6.
40. Geng LY, Shi ZZ, Dong Q, Cai XH, Zhang YM, Cao W, et al. Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas. World J Gastroenterol 2007;13:2305-11.
41. Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, Gustavsson I, et al. Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst 2013;105:624-33.
42. Shi Y, Li L, Hu Z, Li S, Wang S, Liu J, et al. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet 2013;45:918-22.
43. Bodelon C, MadeleineMM,Johnson LG, Du Q, Galloway DA, Malkki M, et al. Genetic variation in the TLR and NF-kappaB pathways and cervical and vulvar cancer risk: A population-based case-control study. Int J Cancer 2014;134:437-44.
44. Kumar R, Selth LA, Schulz RB, Tay BS, Neilsen PM, Callen DF. Genome-wide mapping of ZNF652 promoter binding sites in breast cancer cells. J Cell Biochem 2011;112:2742-7.
45. Barrett CW, Fingleton B, Williams A, Ning W, Fischer MA, Washington MK, et al.MTGR1is required for tumorigenesis in the murineAOM/DSS colitis-associated carcinoma model. Cancer Res 2011;71:1302-12.
46. Ehlting C, Ronkina N, Bohmer O, Albrecht U, Bode KA, Lang KS, et al. Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopoly-saccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3. J Biol Chem 2011;286:24113-24.
47. Holzer TR, Fulford AD, Arkins AM, Grondin JM, Mundy CW, Nasir A, et al. Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks. Anticancer Res 2011;31:2073-81.
48. Chiang J, Hodes RJ. Cbl enforces Vav1 dependence and a restricted pathway of T cell development. PLoS ONE 2011;6:e18542.
49. Morabito F, De Filippi R, Laurenti L, Zirlik K, Recchia AG, Gentile M, et al. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. Blood 2011;118: 6353-61.
50. Fallah-Arani F, Schweighoffer E, Vanes L, Tybulewicz VL. Redundant role for Zap70 in B cell development and activation. Eur J Immunol 2008;38:1721-33.
51. Takeuchi A, Itoh Y, Takumi A, Ishihara C, Arase N, Yokosuka T, et al. CRTAM confers late-stage activation of CD8? T cells to regulate retention within lymph node. J Immunol 2009;183:4220-8.
52. Steigerwald J, Raum T, Pflanz S, Cierpka R, Mangold S, Rau D, et al. Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells. MAbs 2009;1:115-27.
53. Liu DB, Gu ZD, Cao XZ, Liu H, Li JY. Immunocytochemical detection of HoxD9 and Pbx1 homeodomain protein expression in Chinese esophageal squamous cell carcinomas. World J Gastroenterol 2005;11: 1562-6.
54. Shiozawa Y, Pedersen EA, Taichman RS. GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche. Exp Hematol 2010;38:132-40.
55. Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS. Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer 2010;10:89.
56. Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling. Cell 2011;145:92-103.
57. Ying J, Li H, Cui Y, Wong AH, Langford C, Tao Q. Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia 2006;20:1173-5.
58. Nakayama M, Takeda K, Kawano M, Takai T, Ishii N, Ogasawara K. Natural killer (NK)-dendritic cell interactions generate MHC class IIdressed NK cells that regulate CD4? T cells. Proc Natl Acad Sci U S A 2011;108:18360-5.
59. Takata K, Kinoshita M, Okuno T, Moriya M, Kohda T, Honorat JA, et al. The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells. PLoS ONE 2011;6:e27644.
60. Cui W, Liu Y, Weinstein JS, Craft J, Kaech SM. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8? T cells. Immunity 2011;35:792-805.
61. Gridley DS, Pecaut MJ, Rizvi A, Coutrakon GB, Luo-Owen X, Makinde AY, et al. Low-dose, low-dose-rate proton radiation modulates CD4(?) T cell gene expression. Int J Radiat Biol 2009;85:250-61.
62. Smith AJ, Li Q, Wietgrefe SW, Schacker TW, Reilly CS, Haase AT. Host genes associated with HIV-1 replication in lymphatic tissue. J Immunol 2010;185:5417-24.
63. Segatto O, Anastasi S, Alema S. Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors. J Cell Sci 2011; 124:1785-93.
64. Bian Y, Hall B, Sun ZJ, Molinolo A, Chen W, Gutkind JS, et al. Loss of TGF-beta signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene 2012;31:3322-32.
65. Goudie DR, D'Alessandro M, Merriman B, Lee H, Szeverenyi I, Avery S, et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet 2011;43:365-9.
66. Liao D. Emerging roles of the EBF family of transcription factors in tumor suppression. Mol Cancer Res 2009;7:1893-901.
67. Perez-Vera P, Reyes-Leon A, Fuentes-Panana EM. Signaling proteins and transcription factors in normal and malignant early B cell development. Bone Marrow Res 2011;2011:502751.
68. Jameson MJ, Beckler AD, Taniguchi LE, Allak A, Vanwagner LB, Lee NG, et al. Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells. Mol Cancer Ther 2011;10:2124-34.
69. Gray P, Dagvadorj J, Michelsen KS, Brikos C, Rentsendorj A, Town T, et al. Myeloid differentiation factor-2 interacts with Lyn kinase and is tyrosine phosphorylated following lipopolysaccharide-induced activation of the TLR4 signaling pathway. J Immunol 2011;187:4331-7.
70. Faccio R. Immune regulation of the tumor/bone vicious cycle. Ann N Y Acad Sci 2011;1237:71-8.
71. Ali MY, Grimm CF, Ritter M, Mohr L, Allgaier HP, Weth R, et al. Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol 2005;43:817-22.
72. Ushijima H, Kunisada T, Ami Y, Tsuchie H, Takahashi I, Klocking HP, et al. Characterization of human immunodeficiency virus-1-infected cells of myeloid-monocytic lineage (ML-1, HL-60, THP-1, U-937). J Acquir Immune Defic Syndr 1992;5:1001-4.